[go: up one dir, main page]

CL2016001510A1 - Células madre derivadas de musculo de mamifero - Google Patents

Células madre derivadas de musculo de mamifero

Info

Publication number
CL2016001510A1
CL2016001510A1 CL2016001510A CL2016001510A CL2016001510A1 CL 2016001510 A1 CL2016001510 A1 CL 2016001510A1 CL 2016001510 A CL2016001510 A CL 2016001510A CL 2016001510 A CL2016001510 A CL 2016001510A CL 2016001510 A1 CL2016001510 A1 CL 2016001510A1
Authority
CL
Chile
Prior art keywords
stem cells
cells derived
mammalian muscle
muscle
mammalian
Prior art date
Application number
CL2016001510A
Other languages
English (en)
Inventor
Didier Serteyn
Justine Ceusters
Original Assignee
Univ Liege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liege filed Critical Univ Liege
Publication of CL2016001510A1 publication Critical patent/CL2016001510A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1323—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from skeletal muscle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

MÉTODO PARA PREPARAR CÉLULAS MADRE MESENQUIMÁTICAS A PARTIR DE TEJIDO MUSCULAR DE MAMÍFERO; POBLACIÓN DE CÉLULAS MADRE; COMPOSICIÓN FARMACÉUTICA O VETERINARIA QUE LAS COMPRENDE; Y USO EN EL TRATAMIENTO DE DIVERSOS TRASTORNOS.
CL2016001510A 2013-12-19 2016-06-15 Células madre derivadas de musculo de mamifero CL2016001510A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13198477 2013-12-19

Publications (1)

Publication Number Publication Date
CL2016001510A1 true CL2016001510A1 (es) 2016-12-30

Family

ID=49876422

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001510A CL2016001510A1 (es) 2013-12-19 2016-06-15 Células madre derivadas de musculo de mamifero

Country Status (14)

Country Link
US (1) US10633633B2 (es)
EP (1) EP3083944B1 (es)
JP (1) JP6713412B2 (es)
AU (1) AU2014365165B2 (es)
BR (1) BR112016014116B1 (es)
CA (1) CA2934100C (es)
CL (1) CL2016001510A1 (es)
DK (1) DK3083944T3 (es)
ES (1) ES2846760T3 (es)
GB (1) GB2536366B (es)
IL (1) IL246276B (es)
MX (1) MX2016007926A (es)
PT (1) PT3083944T (es)
WO (1) WO2015091210A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016007926A (es) 2013-12-19 2016-12-15 Université de Liège Celulas madre derivadas de musculo de mamifero.
EP3388511A1 (en) * 2017-04-12 2018-10-17 Revatis SA New uses of mammalian muscle derived stel cells
EP3388513A1 (en) * 2017-04-12 2018-10-17 Revatis SA Method of obtaining differentiated cells from muscle derived progenitor cells
CN111225676A (zh) * 2017-10-17 2020-06-02 国立大学法人广岛大学 诱导骨软骨修复的多能性干细胞
CN108245709A (zh) * 2017-12-13 2018-07-06 上海昊海生物科技股份有限公司 一种预防包膜挛缩的仿生型几丁糖填充剂及其制备方法
WO2021092199A1 (en) * 2019-11-08 2021-05-14 Kansas State University Research Foundation Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells
AU2021201033A1 (en) * 2020-02-21 2021-09-09 Revatis Sa Culturing of stem cells
WO2025176642A1 (en) 2024-02-19 2025-08-28 Revatis S.a. Process for the preparation of an extracellular vesicle composition, extracellular vesicle composition and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047712A1 (es) * 2002-09-07 2006-02-15 Royal Veterinary College Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
KR20110013450A (ko) * 2008-05-07 2011-02-09 본 테라퓨틱스 소시에테아노님 간엽 줄기 세포 및 골-형성 세포
EP2611906B1 (en) * 2010-08-31 2024-01-03 Gallant Pet, Inc. Systemic, allogenic stem cell therapies for treatment of diseases in cats and dogs
MX2016007926A (es) 2013-12-19 2016-12-15 Université de Liège Celulas madre derivadas de musculo de mamifero.

Also Published As

Publication number Publication date
CA2934100A1 (en) 2015-06-25
JP2017500860A (ja) 2017-01-12
JP6713412B2 (ja) 2020-06-24
IL246276A0 (en) 2016-07-31
GB201604786D0 (en) 2016-05-04
BR112016014116A2 (pt) 2017-08-08
CA2934100C (en) 2021-10-19
NZ720440A (en) 2021-10-29
AU2014365165B2 (en) 2020-11-05
ES2846760T3 (es) 2021-07-29
MX2016007926A (es) 2016-12-15
IL246276B (en) 2021-02-28
US10633633B2 (en) 2020-04-28
DK3083944T3 (da) 2021-02-15
WO2015091210A1 (en) 2015-06-25
BR112016014116B1 (pt) 2022-12-13
PT3083944T (pt) 2021-02-17
GB2536366A (en) 2016-09-14
EP3083944B1 (en) 2020-12-09
GB2536366B (en) 2019-10-23
HK1222886A1 (zh) 2017-07-14
EP3083944A1 (en) 2016-10-26
US20160186142A1 (en) 2016-06-30
AU2014365165A1 (en) 2016-06-09

Similar Documents

Publication Publication Date Title
CL2016001510A1 (es) Células madre derivadas de musculo de mamifero
MX2015003140A (es) Formulaciones de enzalutamida.
IL254734B1 (en) Modified t cells and methods of making and using the same
BR112015015891A8 (pt) Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
UY34651A (es) ?formas de dosificación de liberación inmediata resistentes a la manipulación, procesos para prepararlas, métodos y usos de las mismas?..
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
DOP2015000185A (es) Pirimidinas fusionadas sustituidas con trifluorometilo y sus usos
EP4292550A3 (en) Anchor delivery system
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
PL3044104T3 (pl) Ampułka do cieczy medycznej i sposób wytwarzania ampułki
HUE045629T2 (hu) Készítmények, alkalmazások és eljárások anyagcsere rendellenességek és betegségek kezelésére
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
MX2015015409A (es) Proceso para la preparacion de eritrocitos cargados con una o mas sustancias de interes farmaceutico y eritrocitos asi obtenidos.
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
UY34725A (es) Nuevos derivados de tienopirimidina, procesos para su preparación y sus usos terapéuticos.
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
MX2016012823A (es) Inserto vaginal.
DK3419673T3 (da) Genterapi til behandling af sygdom i nethindens tapceller
IL250495B (en) Stem cell compositions and methods of producing stem cells for therapeutic applications
UY35438A (es) Procedimiento para preparar inhibidores de la glucosilceramida sintasa.
FR3009956B1 (fr) Composition hydratante sous forme d’emulsion huile-dans-eau ; procede de soin hydratant
BR112015028737A2 (pt) métodos para a produção e/ou purificação de hormônios
BR112017002915A2 (pt) processo para manufaturar um dispositivo de uso médico customizável e dispositivo obtido pelo dito processo
HRP20180345T1 (hr) Derivati sterola i njihova upotreba u liječenju bolesti koje uključuju transformirane astrocitne stanice, ili u liječenju zloćudnih hemopatija